Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
mRNA | PRKCQ | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
mRNA | BCL11A | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | GDAP1L1 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-09 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | ATXN7L3B | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
mRNA | ZNF420 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |